Crown Castle Inc. (CCI)
| Previous close | 118.43 |
| Open | 119.48 |
| Bid | 117.94 x 800 |
| Ask | 117.97 x 800 |
| Day's range | 117.71 - 119.50 |
| 52-week range | 84.72 - 153.98 |
| Volume | |
| Avg. volume | 3,679,106 |
| Market cap | 51.219B |
| Beta (5Y monthly) | 0.76 |
| PE ratio (TTM) | 32.99 |
| EPS (TTM) | 3.58 |
| Earnings date | 23 Jan 2024 - 29 Jan 2024 |
| Forward dividend & yield | 6.26 (5.29%) |
| Ex-dividend date | 14 Dec 2023 |
| 1y target est | 105.07 |
- Investing.com
Nike assumed at Buy, 'near-term challenges well understood': 4 big analyst picks
Here is your Pro Recap of the biggest analyst picks you may have missed since yesterday: Buy assumptions at Nike and Block, and upgrades at Crown Castle and Apellis Pharmaceuticals. Goldman Sachs assumed coverage on Nike (NYSE:NKE) with a Buy rating and a price target of $139.00 (from $136 prior), as reported in real-time on InvestingPro. The analysts expect an upturn in Nike's earnings growth.
GlobeNewswireCrown Castle Announces Pricing of Senior Notes Offering
HOUSTON, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) (“Crown Castle”) announced today that it has priced its previously announced public offering of 5.600% Senior Notes due 2029 and 5.800% Senior Notes due 2034 in aggregate principal amounts of $750 million and $750 million, respectively. The Senior Notes due 2029 will have an interest rate of 5.600% per annum and will be issued at a price equal to 99.661% of their face value to yield 5.673%. The Senior Notes due 2034 will ha
Insider Monkey15 Best High Yield Stocks To Buy
In this article, we discuss 15 best high-yield stocks to buy. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Best High Yield Stocks To Buy. Investors exploring dividend stocks often place significant focus on dividend yields and dividend growth. Both these factors […]
